Effects of β-carotene Supplementation on Cancer and Heart Disease in Women
Author Information
Author(s): Lee I-M, Cook N R, Manson J E, Buring J E
Primary Institution: Brigham and Women's Hospital and Harvard Medical School
Hypothesis
Does β-carotene supplementation affect the incidence of cancer and cardiovascular disease based on baseline plasma levels?
Conclusion
The study found no effect of β-carotene supplementation on the risk of cancer or cardiovascular disease in women, regardless of their baseline plasma β-carotene levels.
Supporting Evidence
- Previous studies showed mixed results on the benefits of β-carotene supplementation.
- The study included a large sample of women and used rigorous methods to assess outcomes.
- Findings suggest that β-carotene supplementation does not provide benefits for cancer or cardiovascular disease.
Takeaway
The study looked at whether taking β-carotene helps prevent cancer or heart disease in women, and it found that it doesn't seem to help at all.
Methodology
A nested case-control study within the Women's Health Study, comparing women with cancer and cardiovascular disease to matched controls.
Potential Biases
Potential bias due to the limited sample of women who provided blood samples and the short treatment duration.
Limitations
The β-carotene treatment lasted only 2.1 years, limiting long-term evaluation, and only 71% of participants provided baseline blood samples.
Participant Demographics
Women aged 45 and older, with a mean age of 56.7 years; 15% were smokers.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website